tiprankstipranks
Trending News
More News >
Coherus Biosciences (CHRS)
NASDAQ:CHRS
US Market
Advertisement

Coherus Biosciences (CHRS) Technical Analysis

Compare
1,606 Followers

Technical Sentiment

Overall Consensus
Buy
14Bullish
4Neutral
4Bearish
Technical Analysis Consensus
Neutral
3Bullish
4Neutral
3Bearish
Moving Average Consensus
Strong Buy
11Bullish
0Neutral
1Bearish
Coherus Biosciences’s (CHRS) Moving Averages Convergence Divergence (MACD) indicator is 0.02, suggesting Coherus Biosciences is a Sell.
Coherus Biosciences’s (CHRS) 20-Day exponential moving average is 0.92, while Coherus Biosciences’s (CHRS) share price is $1.02, making it a Buy.
Coherus Biosciences’s (CHRS) 50-Day exponential moving average is 0.89, while Coherus Biosciences’s (CHRS) share price is $1.02, making it a Buy.

Coherus Biosciences (CHRS) Pivot Points

Aug 15, 2025, 09:00 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.87
0.89
0.95
0.97
1.03
1.05
1.11
Fibonacci
0.89
0.92
0.94
0.97
1.00
1.02
1.05
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Coherus Biosciences (CHRS) Moving Averages

Aug 15, 2025, 09:00 PM
Period
Simple
Exponential
MA5
0.93Buy
0.96Buy
MA10
0.91Buy
0.94Buy
MA20
0.94Buy
0.92Buy
MA50
0.86Buy
0.89Buy
MA100
0.88Buy
0.91Buy
MA200
1.03Sell
1.01Buy
Coherus Biosciences’s (CHRS) 10-Day exponential moving average is 0.94, while Coherus Biosciences’s (CHRS) share price is $1.02, making it a Buy.
Coherus Biosciences’s (CHRS) 100-Day exponential moving average is 0.91, while Coherus Biosciences’s (CHRS) share price is $1.02, making it a Buy.
Coherus Biosciences’s (CHRS) stock price is $1.02 and Coherus Biosciences’s (CHRS) 50-day simple moving average is 0.86, creating a Buy signal.
Coherus Biosciences’s (CHRS) stock price is $1.02 and Coherus Biosciences’s (CHRS) 100-day simple moving average is 0.88, creating a Buy signal.
Coherus Biosciences’s (CHRS) stock price is $1.02 and Coherus Biosciences’s (CHRS) 200-day simple moving average is 1.03, creating a Sell signal.

Coherus Biosciences (CHRS) Technical Indicators

Aug 15, 2025, 09:00 PM
Name
Value
Implied Action
RSI (14)
60.59
Neutral
STOCH (9,6)
81.23
Sell
STOCHRSI (14)
50.00
Neutral
MACD (12,26)
0.02
Sell
ADX (14)
17.64
Buy
Williams %R
-38.24
Buy
CCI (14)
71.38
Neutral
ATR (14)
0.07
-
Ultimate Oscillator
54.41
Neutral
ROC
-1.92
Sell
Coherus Biosciences’s (CHRS) Relative Strength Index (RSI) is 60.59, creating a Neutral signal.
Coherus Biosciences’s (CHRS) Trend Strength Indicator (ADX) is 17.64, creating a Buy signal.
Coherus Biosciences’s (CHRS) Commodity Channel Index (CCI) is 71.38, creating a Neutral signal.
Coherus Biosciences’s (CHRS) Price Rate of Change (ROC) is -1.92, creating a Sell signal.

FAQ

Is CHRS a Buy, Hold, or Sell?
Based on CHRS’s technical indicators, CHRS is a Buy.
    What is CHRS’s RSI (14)?
    CHRS’s RSI (14) is 60.59, which suggests CHRS is a Neutral.
      What is CHRS’s MACD?
      CHRS’s MACD is 0.02, which suggests CHRS is a Sell.
        What is CHRS’s 5-day moving average?
        CHRS’s 5-day moving average is 0.93, which suggests CHRS is a Buy.
          What is CHRS’s 20-day moving average?
          CHRS 20-day moving average is 0.94, which suggests CHRS is a Buy.
            What is CHRS’s 50-day moving average?
            CHRS’s 50-day moving average is 0.86, which suggests CHRS is a Buy.
              What is CHRS’s 200-day moving average?
              CHRS’s 200-day moving average is 1.03, which suggests CHRS is a Sell.
                What is CHRS’s Williams % R (14)?
                CHRS’s Williams % R (14) is -38.24, which suggests CHRS is a Buy.
                  What is CHRS’s CCI (14)?
                  CHRS’s CCI (14) is 71.38, which suggests CHRS is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis